1333384-43-2

Basic information

• Product Name: tert-butyl 4-(hydroxyMethyl)bicyclo[2.2.2]octan-1-ylcarbaMate
• Synonyms: tert-butyl 4-(hydroxyMethyl)bicyclo[2.2.2]octan-1-ylcarbaMate;Carbamic acid, N-[4-(hydroxymethyl)bicyclo[2.2.2]oct-1-yl]-, 1,1-dimethylethyl ester;EOS-61112;Tert-Butyl (4-(Hydroxymethyl)Bicyclo[2.2.2]Octan-1-Yl)Carbamate(WX641163)
• CAS NO: 1333384-43-2
• Molecular Formula: C14H25NO3
• Molecular Weight: 255.3532
• EINECS: -0
• Mol File: 1333384-43-2.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: tert-butyl 4-(hydroxyMethyl)bicyclo[2.2.2]octan-1-ylcarbaMate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-(hydroxyMethyl)bicyclo[2.2.2]octan-1-ylcarbaMate(1333384-43-2)
• EPA Substance Registry System: tert-butyl 4-(hydroxyMethyl)bicyclo[2.2.2]octan-1-ylcarbaMate(1333384-43-2)

Safety Data

• Hazardous Substances Data: 1333384-43-2(Hazardous Substances Data)

Usage

General Description

Tert-butyl 4-(hydroxyMethyl)bicyclo[2.2.2]octan-1-ylcarbaMate is a chemical compound with the molecular formula C15H27NO3. It is derived from a bicyclic structure and contains a carbaMate group, which is a type of carbamate functional group. The compound features a tert-butyl group, a hydroxymethyl group, and a bicyclo[2.2.2]octan-1-yl group. It is used in the pharmaceutical industry for its potential as a drug candidate or as a building block for the synthesis of other compounds. Further research and testing are likely required to determine the specific properties and potential applications of this chemical.

Upstream product

• 94-60-0 dimethyl 1,4-cyclohexane dicarboxylate 
• 106004-06-2 dimethyl 1-(2'-chloroethyl)cyclohexane-1,4-dicarboxylate 
• 1459-96-7 dimethyl bicyclo[2.2.2]octane-1,4-dicarboxylate 
• 18720-35-9 bicyclo[2.2.2]octane-1,4-dicarboxylic acid monomethyl ester 
• 854214-59-8 4-amino-bicyclo[2.2.2]octane-1-carboxylic acid ; hydrochloride 
• 949153-20-2 ethyl 4-amino-bicyclo[2.2.2]octane-1-carboxylate hydrochloride 
• 105176-66-7 (4-aminobicyclo[2.2.2]octan-1-yl)methanol 
• 24424-99-5 di-tert-butyl dicarbonate 
• 135908-45-1 ethyl 4-aminobicyclo[2.2.2]octane-1-carboxylate 
• 13595-17-0 4-amino-bicyclo[2.2.2]octane-1-carboxylic acid 
• 943845-74-7 methyl 4-((tert-butoxycarbonyl)amino)bicyclo[2.2.2]octane-1-carboxylate 
• 863304-76-1 4-((tert-butoxycarbonyl)amino)bicyclo[2.2.2]octane-1-carboxylic acid 

Relevant articles and documents

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

The invention provides anti-VISTA antibody drug conjugates which may be used for targeted delivery of anti-inflammatory agents such as steroids to immune cells, e.g., myeloid cells. The invention also provides methods of using anti-VISTA antibody drug conjugates in the treatment of inflammatory and/or autoimmune conditions and/or for alleviating the toxicity of anti-inflammatory agents such as steroids.

SSAO INHIBITORS AND USE THEREOF

Provided are a compound of formula (I') or (I), a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of SSAO, a pharmaceutical composition comprising a compound of formula (I') or (I), and a method of treating or preventing a disease in which SSAO plays a role.

COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL TOLL-LIKE RECEPTORS

The invention disclosed herein relates to 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridinyl compounds and 4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridinyl compounds of Formula (A), pharmaceutical compositions comprising such compounds and the use of such compounds in the treatment of autoimmune diseases.